Submit Deal

CIDARA THERAPEUTICS

HQ - San Diego, California

Summary

Cidara Therapeutics is a biotechnology company developing drug-Fc conjugate (DFC) therapeutics.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 7.18 B

Avg. Deal Size£ 3.59 B

Market Context

Senior Management

Jeffrey Stein
CEO
Frank Karbe
CFO

Sort

lifesci partners

HQ - New York

pr advisors (1)

1 Shared Deal

1 For

£ 194 M

Total Value

deerfield management

pr advisors (1)

1 Shared Deal

1 Opposite

£ 194 M

Total Value

gibson dunn & crutcher

HQ - Los Angeles

legal advisors (2)

2 Shared Deals

2 Opposite

£ 7.18 B

Total Value

evercore

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 6.99 B

Total Value

goldman sachs

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 6.99 B

Total Value

cooley

HQ - Palo Alto

legal advisors (1)

1 Shared Deal

1 For

£ 6.99 B

Total Value

prosek partners

HQ - New York

pr advisors (1)

1 Shared Deal

1 For

£ 6.99 B

Total Value

fried frank harris shriver & jacobson

HQ - New York

legal advisors to financial advisors (1)

1 Shared Deal

1 For

£ 6.99 B

Total Value

bank of america

HQ - Charlotte

financial advisors (1)

1 Shared Deal

1 Opposite

£ 6.99 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy